Diagnosing NF2 in neonates is challenging due to the subtle and variable presentation. Common initial indicators might include hearing loss, which can be assessed through newborn hearing screenings. Additionally, if there is a family history of NF2, genetic testing can be performed to identify mutations in the NF2 gene. In some cases, imaging studies such as MRI may be utilized to detect early tumor development.
